Fast Five Quiz: Advanced and Metastatic Prostate Cancer Treatment

Daniel S. Schwartz, MD, MBA


May 02, 2022

The Whitmore-Jewett system classifies prostate cancer as stage A, B, C, or D. However, this classification system is no longer widely used because prostate cancer does not always progress sequentially.

Several reliable pretreatment risk classification tools are available for prostate cancer. In a 2019 study, the Memorial Sloan Kettering Cancer Center nomogram, Cancer of the Prostate Risk Assessment score, and Cambridge Prognostic Groups risk group system performed best in predicting prostate cancer death. Utilization of these tools in clinical practice may aid in making treatment decisions for patients.

Extracapsular extension of the tumor is a characteristic of stage T3a prostate cancer, whereas invasion of the seminal vesicle(s) denotes stage T3b prostate cancer.

Learn more about the staging of advanced and metastatic prostate cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.